| Identification | Back Directory | [Name]
2(1H)-Isoquinolinepropanol, β,β-difluoro-1-[4-[2-[3-(fluoromethyl)-1-azetidinyl]ethoxy]phenyl]-3,4-dihydro-6-hydroxy-3-methyl-, (1S,3S)- | [CAS]
2136600-69-4 | [Synonyms]
Estrogen receptor antagonist 5
2(1H)-Isoquinolinepropanol, β,β-difluoro-1-[4-[2-[3-(fluoromethyl)-1-azetidinyl]ethoxy]phenyl]-3,4-dihydro-6-hydroxy-3-methyl-, (1S,3S)- | [Molecular Formula]
C25H31F3N2O3 | [MOL File]
2136600-69-4.mol | [Molecular Weight]
464.53 |
| Hazard Information | Back Directory | [Uses]
Estrogen receptor antagonist 5 is a potent antagonist of Estrogen receptor. The estrogen receptor is a ligand-activated transcriptional regulatory protein that mediates induction of a variety of biological effects through its interaction with endogenous estrogens. Estrogen receptor antagonist 5 has the potential for the research of metastatic disease (extracted from patent WO2017174757A1, compound 165)[1]. | [References]
[1] Sharada Labadie, et al. Tetrahydroisoquinoline estrogen receptor modulators and uses thereof. Patent WO2017174757A1. |
|
|